The questions on which the case turns are whether genetic patents help or hamper research, and whether patients should have to pay a license fee to a biotechnology corporation to be tested for predisposition to disease.
此案争论的焦点在于基因专利究竟帮助还是阻碍了相关研究的发展，以及患者是否必需向生物技术公司付费，才能测试自己的疾病倾向。